Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer.
Year: 1995
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Authors: V Valero, F A Holmes, R S Walters, R L Theriault, L Esparza, G Fraschini, G A Fonseca, R E Bellet, A U Buzdar, G N Hortobagyi
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W1955744924